Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Ide-cel Combination Therapy for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
Nashville, Tennessee
This trial is testing the safety and efficacy of a new drug, bb2121, in combination with other therapies, in adult patients with relapsed or refractory multiple myeloma. There are three arms in the trial testing different combinations of drugs. The study will first determine the best dose of bb2121 (Phase 1), and then expand to testing the efficacy of the combinations in a larger group of patients (Phase 2).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service